The iPSC Characterization Kit Market Size is predicted to grow at an 15.54 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
A variety of delicate instruments are included in the iPSC characterization kit (induced pluripotent stem cell) for the phenotypic evaluation of the pluripotent state of human embryonic stem & induced pluripotent stem cells. Compared to embryonic stem cells (ESCs), induced pluripotent stem cells have several advantages, including avoiding the ethical concerns surrounding stem cells and offering the most significant degree of versatility for use in cell-based research. In recent years, these benefits have given induced pluripotent stem cells (iPSCs) a considerable boost, establishing a promising market for iPSC characterization kits. The strong pipeline for cell therapies derived from iPSCs and new iPSC applications is expected to accelerate market growth. Furthermore, the demand for iPSC characterization kits is expanding as a result of an increase in the prevalence of chronic diseases.
Additionally, induced pluripotent stem cells can be used to treat chronic diseases like diabetes, cancer, cancer, and heart disease, hence driving the iPSC characterization kit market. According to the Partnership to Fight Chronic Disorder (PFCD) survey, out of 133 million Americans, 45% of the population had at least one chronic disorder. In addition, it was calculated that chronic diseases account for 7 out of 10 deaths in the USA or roughly 1.7 million deaths, and that induced pluripotent stem cell therapy can prevent these deaths. Hence, the increased demand for induced pluripotent stem cell therapy is being driven by this surge in the prevalence of chronic disorders, which aids in the iPSC characterization kit market expansion.
The iPSC characterization kit market is segmented by type and application. Based on the type, the market is segmented into alkaline phosphatase staining assay, pluripotency markers (protein) and pluripotency markers (mRNA). Based on the application, the market is segmented into cancer research center, pathology laboratory, academic and research, contract research organizations and others.
The alkaline phosphatase staining assay category dominated the market in 2021. It is a stem cell imaging product used to stain pluripotent stem cells (PSCs) differentially. Over two hours, the dye diffuses out and acts as a cell-permeable fluorescent substrate for alkaline phosphatase (AP) that is non-toxic to cells. A high signal above the background enables the identification of pluripotent stem cells. Since it preserves stem cell viability, the alkaline phosphatase live stain is perfect for colony screening in the early stages of the reprogramming procedure. It can also be employed as a negative selection method to spot undifferentiated cells in advanced phases.
The contract research organizations category dominated the market in 2021 due to the expanding emphasis on stem cell cytology and pathophysiology research and the expansion of public-private funding to assist the development and commercialization of stem cell products. A corporation that supports the pharmaceutical, biotechnology, and medical device sectors by contracting out research activities is known as a contract research organization (CRO). A CRO might offer commercialization, clinical trial management, pharmacovigilance, clinical development, outcomes research, and real-world evidence, among other services.
The North American iPSC characterization kit market is expected to register the highest market share. Vital industry players are well represented in the area, and significant private and public financing for research institutes is a key factor in this situation. In addition, developing the iPSC characterization kit market is aided by a robust infrastructure for R&D and application scenarios, including tissue engineering and toxicity screening. It is projected that the region will maintain its dominance. In addition, Asia Pacific is projected to increase in the global iPSC characterization kit market. Induced pluripotent stem cell use is anticipated to be fueled by substantial market expansion in nations like Japan and China, as well as growing interest in regenerative medicine in the area, which will further fuel the growth of the iPSC characterization kit market. Although there isn't a clear legislative framework for the iPSC business, regional governments are making concerted attempts to change that. Those efforts are anticipated to support the development of the iPSC characterization kit market.
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 15.54 % from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Type, Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Merck KGaA, Takara Bio, Thermo Fisher Scientific, BD Biosciences, Applied StemCell, Amsbio, Bio-Techne, ALSTEM, STEMCELL Technologies, System Biosciences, Applied Biological Materials, Creative Bioarray, Elixirgen Scientific and Miltenyi Biotec. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Type-
By Application-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.